Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

American Diversified Holdings Corp (OTCMKTS:ADHC) stock performance was -16.67% in last session and finished the day at $0.0375. Traded volume was 506,482.00million shares in the last session. The beta of the stock remained 3.20. OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in all ongoing early-stage trials of two of its experimental cancer drugs over concerns of bone damage. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) … Continue reading Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

Small Cap Losers: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Altisource Asset Management (NYSEMKT:AAMC), Oncomed Pharmaceuticals (NASDAQ:OMED), Agios Pharmaceuticals (NASDAQ:AGIO)

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from a Phase 1 study of the selective estrogen receptor modulator (SERM) lasofoxifene were featured in a poster presentation today at ICE/ENDO 2014 in Chicago. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) stock performance was -5.92% in last session and finished the day at $62.35. Traded volume was 400.60K shares in the last session and the average volume of the … Continue reading Small Cap Losers: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Altisource Asset Management (NYSEMKT:AAMC), Oncomed Pharmaceuticals (NASDAQ:OMED), Agios Pharmaceuticals (NASDAQ:AGIO)

Corcept Therapeutics Inc (NASDAQ:CORT) Director G Leonard Baker, Jr. bought 103,386 shares of the stock in a transaction that occurred on Wednesday, June 11th. The stock was purchased at an average cost of $2.32 per share, for a total transaction of $239,855.52. Following the completion of the transaction, the director now directly owns 578,389 shares of the company’s stock, valued at approximately $1,341,862. Corcept Therapeutics … Continue reading Healthcare losers: Corcept Therapeutics Incorporated (NASDAQ:CORT), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Anika Therapeutics (NASDAQ:ANIK), Oncomed Pharmaceuticals (NASDAQ:OMED), Cesca Therapeutics (NASDAQ:KOOL)